ki-67 shows proven clinical utility as a predictive clincal biomarkers for breast cancer
Published 11 years ago • 3.1K plays • Length 10:05Download video MP4
Download video MP3
Similar videos
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
1:52
dr. ellis discusses ki67 as a treatment monitoring biomarker
-
2:31
what is ki67?
-
1:19
dr. nielsen on the pros and cons of the ki67 assay in breast cancer
-
0:49
dr. nielsen on the clinical utility of ki67 in breast cancer
-
1:01
dr. nielsen on the challenges of using ki67 as a tool in breast cancer
-
9:21
cancer treatment results incoming!? feeling positive about scans (and life!)
-
7:00
the doctor is in: mammograms, results and breast cancer
-
2:56
ki-67 (protein)
-
0:31
new technology is changing how doctors detect breast cancer
-
2:25
comment: lumina results show that women with low levels of the ki67 biomarker can avoid outcomes...
-
1:06
breast cancer research
-
1:12
the use of ki-67, a proliferation marker, for guiding treatment decisions in breast cancer patients
-
2:54
what is ki-67 or ki67? how to pronounce ki-67 or ki67
-
27:27
cde series 9 - biomarkers and pdl1 in breast cancer - what you need to know
-
2:52
ki67 helps chromosomes keep their distance
-
1:08
the decisiondx®-melanoma test complements current melanoma staging
-
2:01
how do biomarker test results impact a breast cancer patient’s prognosis?
-
2:07
lumina results: women with low levels of the ki67 biomarker can avoid outcomes related to rt
-
3:17
dr. goncalves discusses the development of a standardized ki-67 assay
-
0:50
dr. ellis discusses the cell-proliferation marker ki67